Learn about the disparities in immunotherapy access for Black patients with triple-negative breast cancer (TNBC) compared to white patients.
Vous n'êtes pas connecté
Black patients with bmedlinktriple-negative breast cancer/medlink (TNBC)/b received immunotherapy at significantly lower rates than white patients.
Learn about the disparities in immunotherapy access for Black patients with triple-negative breast cancer (TNBC) compared to white patients.
In recent years, Black patients with triple-negative breast cancer (TNBC) received immunotherapy at significantly lower rates than white patients,...
medlinkEstrogens/medlink are known to bstimulate medlinktumor growth/medlink in medlinkbreast cancer/medlink cells that contain their receptors/b.
A new study reveals that Black women are more likely than white women to die from even the most treatable types of breast cancer. Published Tuesday in...
THURSDAY, Sept. 19, 2024 -- For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by...
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers....
Caring for cancer patients, particularly those with breast cancer, is in focus in several research projects at the University of Borås, Sweden.
Discover how estrogens stimulate tumor growth in breast cancer, affect immunotherapy efficacy, and anti-estrogen drug-enhancing treatment.
MONDAY, Sept. 30, 2024 -- For patients with suspicion for prostate cancer, transperineal biopsy has similar cancer detection rates as transrectal...
New research shows that breast cancer screening with digital breast tomosynthesis significantly raises detection rates and lowers advanced cancer...